Brought to you by 
Philips acquires Respironics for $4.9bn in cash
27 Dec 2007
Executive Summary
Royal Philips Electronics NV has agreed to pay $66 cash (a 27% premium) for each of the outstanding shares of Respironics (medical devices for sleep and respiratory disorders), valuing the transaction at $4.9bn, or about four times Respironics's 2007 sales.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Philips acquires Respironics for $4.9bn in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice